Taken together, our findings demonstrated that HOTAIR regulates ABCG2 induced resistance of GC to oxaliplatin through miR‐195‐5p signalling and illustrate the great potential of developing new therapeutic targets for GC patients. Here, ABCG2 is linked to gastric cancer.